Monday's health stories

OpenAI acquires health tech company Torch
OpenAI says it acquired Torch, a startup that unifies lab results, medications and visit recordings.
Why it matters: Large AI companies are showing more interest in monetizing health care workflows.

Barbie releases first autistic doll as Mattel expands inclusion
Barbie is launching its first autistic doll, developed with the autism community and designed to reflect sensory and communication differences.
Why it matters: Toy giant Mattel is doubling down on inclusion as a growth strategy, using Barbie to reflect a wider range of real-world experiences — and keep the legacy brand relevant with modern parents.

Scoop: Dems make health deal offer with ACA subsidies
Democrats sent Republicans a proposal over the weekend to renew enhanced Affordable Care Act subsidies for three years, paired with extensions of other expiring health programs, sources said.
Why it matters: Sunday's offer shows there's increasing bipartisan sentiment to address long-stalled priorities like overhauling pharmacy benefit manager business practices — even if prospects for the ACA subsidies are much murkier.
What's inside: The proposal from Democratic leadership and health committees was in response to a GOP offer last week to renew funding for community health centers, certain Medicare telehealth flexibilities and other health "extenders" ahead of a Jan. 30 deadline.
- The underlying package being discussed largely mirrors a bipartisan health deal that was due to be included in a 2024 year-end government funding deal before it was jettisoned at the urging of Elon Musk and then-President-elect Trump, sources said.
- That included PBM measures aimed at lowering drug costs, such as "delinking" PBM compensation from the price of a drug in Medicare Part D.
- There is also a measure addressing Medicare hospital costs that would require hospital outpatient departments to use unique identifier numbers in a bid to crack down on what critics say is overbilling.
Between the lines: Democrats' new offer raised the stakes by adding a politically contentious three-year extension of enhanced ACA subsidies that help people afford premiums.
- GOP leadership is sure to reject inclusion of that in the health care package, but there still appears to be progress on the other elements.
- Democrats' new offer also seeks an increase in funding for programs like community health centers, sources said.
The big picture: On a separate track, a bipartisan Senate group has been discussing an ACA subsidy deal that would extend the tax credits along with new restrictions Republicans favor, such as eliminating $0 premiums that critics say fuel fraud.
- There still are considerable hurdles, with most Republicans still opposed to any kind of ACA subsidy extension and many backing new prohibitions on using the money to pay for abortion services.
- President Trump told reporters Sunday night that he "might" veto a subsidy extension, though he was responding to a question about the clean three-year extension, which is unlikely to get to his desk anyway.

Trump funding freeze could stretch child care to a breaking point
Child care providers, already under financial strain, face their greatest test yet as the Trump administration imposes new rules and restrictions on funding.
Why it matters: Federal money underpins the entire industry — vital to millions of parents trying to manage work and family, across all income levels.

There's a biotech boom in dealmaking
Biotech is dominating the (very) early 2026 deals market, whether that be startup fundings, IPOs, or mergers.
Why it matters: This is a reversal of the usual order, in which biotech plays distant second cousin to the sorts of tech that don't need FDA approval.

FDA chief's bid to speed drug reviews hits turbulence
Food and Drug Administration commissioner Marty Makary's flagship effort to overhaul how the agency reviews drugs is facing intensifying scrutiny from Congress and the medical establishment over whether it's putting politics over science.
The big picture: The Commissioner's National Priority Voucher program is intended to expedite reviews of drugs and biologics that are "aligned with U.S. national health priorities."

Pennsylvania Dems squeeze Shapiro as he eyes 2028
Democrats and activists in Pennsylvania are trying to leverage Gov. Josh Shapiro's long-rumored presidential ambitions to try to push him to the left on a key healthcare issue.
Why it matters: Shapiro is the only potential 2028 contender who's also running for reelection as a governor in a swing state this year. He's facing a tricky political challenge — balancing his national aspirations with the demands of his state.






